RE:Beacon raised estimate to 15.50 Canadian, was 12.50 CanadianYup, all looks good for VMD. No competitive bidding for 3 years on vents, broader & stronger relationships with hospitals and others, improved processes with CMS, and Viemend now has got everything in place to move forward with the VA. The $20 million in additional product sales for Q2 is a done deal with some potential for upside on product sales for the balance of the quarter. Only negative was the slower growth in their core business due to the current environment (social distancing, and hestitation to travel related to hiring more RTs and training). The latter slower growth was offset with the $21 million in additional product sales due to Covid. Not to mention, the additional cash from the Federal Covid funding. In summary, all good and the company continues to grow. I would of liked more transparancy of products related to product sales however I respect the company's desire to keep this information confidential as this is a competitive marketf. Even a modest 10% margin brings in an additional $2 million. Record EBITDA numbers was big in terms of valuation and I'm not surprised on the improved margins.